Drug discovery and development
Latest advances in hepatitis C therapy Subscription
The availability of new protease inhibitors is revolutionising the treatment of hepatitis C virus infection.
Pipeline November 2014 Subscription
The latest approvals and positive opinions from the European Medicines Agency.
Biopharmaceuticals: what pharmacists need to know Subscription
A few biopharmaceuticals — medicines such as epoetin alfa and somatostatin — have been around for a while. But as technology progresses, numbers will increase. Similarly, as patents expire, biosimilars are set to become more widely available.